Clinical Trials Directory

Trials / Completed

CompletedNCT00168974

Neuropathic Pain and Fabry Disease

Somatosensoric and Autonomic Disturbances in Female Patients With Fabry Disease

Status
Completed
Phase
Study type
Observational
Enrollment
25 (planned)
Sponsor
Danish Pain Research Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Fabry disease is a rare X-linked lysosomal storage disorder. The mutations result in a deficiency of the lysosomal enzyme α-galactosidase causing accumulation of glycosphingolipids in the vascular endothelial cells and many other tissues. An early sign of the disease is painful small fibre neuropathy presenting in two forms: 1. a constant burning sensation in the hand and feet and 2. Fabry crises consisting of attacks of excruciating pain. Given the X-linked inheritance, male patients are severely affected. Recently attention has been drawn to female patients whether they also show signs of nerve involvement. The purpose of this study is to evaluate the small fibre neuropathy in female Fabry patients. Correlation with X-chromosome inactivation will be attempted. Recombinant human α-galactosidase A is now available for patients. A part of this study is evaluation the long term efficacy of enzyme replacement therapy in female patients with Fabry disease and neuropathy. Male family members with Fabry disease will be examined.

Conditions

Timeline

Start date
2004-01-01
Completion
2007-11-01
First posted
2005-09-15
Last updated
2007-11-16

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00168974. Inclusion in this directory is not an endorsement.

Neuropathic Pain and Fabry Disease (NCT00168974) · Clinical Trials Directory